Gene therapy-mediated overexpression of wild-type MFN2 improves Charcot-Marie-Tooth disease type 2A
Marine Tessier, Zeinab Hamzé, Nathalie Bonello‐Palot…·Nathalie Bernard‐Marissal
This study shows that overexpressing wild-type MFN2 via gene therapy improves CMT2A in mice, restoring ER-mitochondria contacts and motor function even after symptom onset.